nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—CYP1A1—chronic obstructive pulmonary disease	0.299	1	CbGaD
Sildenafil—ADORA2A—Aminophylline—chronic obstructive pulmonary disease	0.188	0.412	CbGbCtD
Sildenafil—CYP2E1—Aminophylline—chronic obstructive pulmonary disease	0.0346	0.0758	CbGbCtD
Sildenafil—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0255	0.0559	CbGbCtD
Sildenafil—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0255	0.0559	CbGbCtD
Sildenafil—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0212	0.0465	CbGbCtD
Sildenafil—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0212	0.0465	CbGbCtD
Sildenafil—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.0194	0.0425	CbGbCtD
Sildenafil—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.0194	0.0425	CbGbCtD
Sildenafil—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.0173	0.0379	CbGbCtD
Sildenafil—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0163	0.0356	CbGbCtD
Sildenafil—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0161	0.0352	CbGbCtD
Sildenafil—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.011	0.0241	CbGbCtD
Sildenafil—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0107	0.0235	CbGbCtD
Sildenafil—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.0105	0.023	CbGbCtD
Sildenafil—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00933	0.0205	CbGbCtD
Sildenafil—PDE5A—pulmonary artery—chronic obstructive pulmonary disease	0.00628	0.355	CbGeAlD
Sildenafil—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00548	0.012	CbGbCtD
Sildenafil—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00517	0.0113	CbGbCtD
Sildenafil—PDE6G—lung—chronic obstructive pulmonary disease	0.00142	0.0802	CbGeAlD
Sildenafil—PDE5A—respiratory system—chronic obstructive pulmonary disease	0.00106	0.0597	CbGeAlD
Sildenafil—PDE5A—connective tissue—chronic obstructive pulmonary disease	0.00093	0.0526	CbGeAlD
Sildenafil—PDE5A—smooth muscle tissue—chronic obstructive pulmonary disease	0.000851	0.0481	CbGeAlD
Sildenafil—ABCC5—bronchus—chronic obstructive pulmonary disease	0.000795	0.045	CbGeAlD
Sildenafil—ABCC10—bronchus—chronic obstructive pulmonary disease	0.000664	0.0376	CbGeAlD
Sildenafil—ABCC10—trachea—chronic obstructive pulmonary disease	0.000597	0.0337	CbGeAlD
Sildenafil—PDE5A—lung—chronic obstructive pulmonary disease	0.000561	0.0317	CbGeAlD
Sildenafil—ABCC4—bronchus—chronic obstructive pulmonary disease	0.000551	0.0312	CbGeAlD
Sildenafil—ABCC5—lung—chronic obstructive pulmonary disease	0.000513	0.029	CbGeAlD
Sildenafil—CYP1A1—respiratory system—chronic obstructive pulmonary disease	0.000449	0.0254	CbGeAlD
Sildenafil—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000439	0.0248	CbGeAlD
Sildenafil—ABCC10—lung—chronic obstructive pulmonary disease	0.000429	0.0242	CbGeAlD
Sildenafil—CYP2E1—respiratory system—chronic obstructive pulmonary disease	0.000409	0.0231	CbGeAlD
Sildenafil—CYP1A1—bronchus—chronic obstructive pulmonary disease	0.000369	0.0209	CbGeAlD
Sildenafil—ABCC4—lung—chronic obstructive pulmonary disease	0.000356	0.0201	CbGeAlD
Sildenafil—CYP1A1—trachea—chronic obstructive pulmonary disease	0.000332	0.0187	CbGeAlD
Sildenafil—CYP1A1—lung—chronic obstructive pulmonary disease	0.000238	0.0135	CbGeAlD
Sildenafil—CYP3A5—lung—chronic obstructive pulmonary disease	0.000233	0.0132	CbGeAlD
Sildenafil—CYP2E1—lung—chronic obstructive pulmonary disease	0.000217	0.0123	CbGeAlD
Sildenafil—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.000748	CcSEcCtD
Sildenafil—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.000748	CcSEcCtD
Sildenafil—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000129	0.000748	CcSEcCtD
Sildenafil—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000129	0.000747	CcSEcCtD
Sildenafil—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000129	0.000747	CcSEcCtD
Sildenafil—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000129	0.000744	CcSEcCtD
Sildenafil—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000129	0.000744	CcSEcCtD
Sildenafil—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.000742	CcSEcCtD
Sildenafil—Infection—Montelukast—chronic obstructive pulmonary disease	0.000128	0.000742	CcSEcCtD
Sildenafil—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000128	0.000741	CcSEcCtD
Sildenafil—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000128	0.00074	CcSEcCtD
Sildenafil—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000128	0.00074	CcSEcCtD
Sildenafil—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000128	0.000738	CcSEcCtD
Sildenafil—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000127	0.000734	CcSEcCtD
Sildenafil—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000127	0.000732	CcSEcCtD
Sildenafil—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000127	0.000731	CcSEcCtD
Sildenafil—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000126	0.000725	CcSEcCtD
Sildenafil—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000125	0.00072	CcSEcCtD
Sildenafil—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.000715	CcSEcCtD
Sildenafil—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000123	0.000712	CcSEcCtD
Sildenafil—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000123	0.000712	CcSEcCtD
Sildenafil—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000123	0.000709	CcSEcCtD
Sildenafil—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000123	0.000708	CcSEcCtD
Sildenafil—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000706	CcSEcCtD
Sildenafil—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000122	0.000702	CcSEcCtD
Sildenafil—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000702	CcSEcCtD
Sildenafil—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000121	0.000699	CcSEcCtD
Sildenafil—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00012	0.000696	CcSEcCtD
Sildenafil—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.000696	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00012	0.000695	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.000695	CcSEcCtD
Sildenafil—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000119	0.000689	CcSEcCtD
Sildenafil—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.000689	CcSEcCtD
Sildenafil—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000119	0.000686	CcSEcCtD
Sildenafil—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000119	0.000685	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00068	CcSEcCtD
Sildenafil—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000118	0.00068	CcSEcCtD
Sildenafil—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000118	0.00068	CcSEcCtD
Sildenafil—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000117	0.000678	CcSEcCtD
Sildenafil—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000117	0.000678	CcSEcCtD
Sildenafil—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000117	0.000675	CcSEcCtD
Sildenafil—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000116	0.000673	CcSEcCtD
Sildenafil—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000116	0.000671	CcSEcCtD
Sildenafil—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000116	0.000671	CcSEcCtD
Sildenafil—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000116	0.00067	CcSEcCtD
Sildenafil—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000116	0.000668	CcSEcCtD
Sildenafil—Injury—Prednisone—chronic obstructive pulmonary disease	0.000115	0.000664	CcSEcCtD
Sildenafil—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000115	0.000664	CcSEcCtD
Sildenafil—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000115	0.000662	CcSEcCtD
Sildenafil—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000114	0.000661	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000658	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000114	0.000658	CcSEcCtD
Sildenafil—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000114	0.000657	CcSEcCtD
Sildenafil—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.000657	CcSEcCtD
Sildenafil—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000114	0.000657	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.000656	CcSEcCtD
Sildenafil—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000652	CcSEcCtD
Sildenafil—Pain—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000652	CcSEcCtD
Sildenafil—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000113	0.000652	CcSEcCtD
Sildenafil—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000113	0.000652	CcSEcCtD
Sildenafil—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000113	0.000651	CcSEcCtD
Sildenafil—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000112	0.00065	CcSEcCtD
Sildenafil—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.000646	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000112	0.000645	CcSEcCtD
Sildenafil—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000644	CcSEcCtD
Sildenafil—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.000642	CcSEcCtD
Sildenafil—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000111	0.00064	CcSEcCtD
Sildenafil—Pain—Montelukast—chronic obstructive pulmonary disease	0.000111	0.000638	CcSEcCtD
Sildenafil—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000638	CcSEcCtD
Sildenafil—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00011	0.000637	CcSEcCtD
Sildenafil—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000635	CcSEcCtD
Sildenafil—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00011	0.000635	CcSEcCtD
Sildenafil—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00011	0.000634	CcSEcCtD
Sildenafil—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000109	0.000632	CcSEcCtD
Sildenafil—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000109	0.000631	CcSEcCtD
Sildenafil—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000109	0.000629	CcSEcCtD
Sildenafil—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000109	0.000628	CcSEcCtD
Sildenafil—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000109	0.000628	CcSEcCtD
Sildenafil—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000109	0.000627	CcSEcCtD
Sildenafil—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000626	CcSEcCtD
Sildenafil—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.000108	0.000625	CcSEcCtD
Sildenafil—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000108	0.000625	CcSEcCtD
Sildenafil—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000108	0.000623	CcSEcCtD
Sildenafil—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000108	0.000623	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.000621	CcSEcCtD
Sildenafil—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000621	CcSEcCtD
Sildenafil—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000616	CcSEcCtD
Sildenafil—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000107	0.000616	CcSEcCtD
Sildenafil—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000106	0.000611	CcSEcCtD
Sildenafil—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000106	0.00061	CcSEcCtD
Sildenafil—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000105	0.000606	CcSEcCtD
Sildenafil—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000105	0.000606	CcSEcCtD
Sildenafil—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000603	CcSEcCtD
Sildenafil—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000104	0.000603	CcSEcCtD
Sildenafil—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000603	CcSEcCtD
Sildenafil—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000104	0.000603	CcSEcCtD
Sildenafil—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000104	0.000601	CcSEcCtD
Sildenafil—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000103	0.000596	CcSEcCtD
Sildenafil—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000103	0.000595	CcSEcCtD
Sildenafil—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000103	0.000595	CcSEcCtD
Sildenafil—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000103	0.000593	CcSEcCtD
Sildenafil—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000103	0.000593	CcSEcCtD
Sildenafil—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000102	0.000592	CcSEcCtD
Sildenafil—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000102	0.00059	CcSEcCtD
Sildenafil—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000102	0.00059	CcSEcCtD
Sildenafil—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000102	0.000589	CcSEcCtD
Sildenafil—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000102	0.000589	CcSEcCtD
Sildenafil—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000584	CcSEcCtD
Sildenafil—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000101	0.000583	CcSEcCtD
Sildenafil—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000101	0.000581	CcSEcCtD
Sildenafil—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.0001	0.00058	CcSEcCtD
Sildenafil—Urticaria—Salbutamol—chronic obstructive pulmonary disease	9.9e-05	0.000572	CcSEcCtD
Sildenafil—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	9.85e-05	0.000569	CcSEcCtD
Sildenafil—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	9.85e-05	0.000569	CcSEcCtD
Sildenafil—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	9.72e-05	0.000562	CcSEcCtD
Sildenafil—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	9.72e-05	0.000562	CcSEcCtD
Sildenafil—Nausea—Tiotropium—chronic obstructive pulmonary disease	9.71e-05	0.000561	CcSEcCtD
Sildenafil—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	9.69e-05	0.00056	CcSEcCtD
Sildenafil—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	9.62e-05	0.000555	CcSEcCtD
Sildenafil—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	9.52e-05	0.00055	CcSEcCtD
Sildenafil—Asthenia—Formoterol—chronic obstructive pulmonary disease	9.47e-05	0.000547	CcSEcCtD
Sildenafil—Asthenia—Arformoterol—chronic obstructive pulmonary disease	9.47e-05	0.000547	CcSEcCtD
Sildenafil—Pruritus—Formoterol—chronic obstructive pulmonary disease	9.34e-05	0.000539	CcSEcCtD
Sildenafil—Pruritus—Arformoterol—chronic obstructive pulmonary disease	9.34e-05	0.000539	CcSEcCtD
Sildenafil—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	9.32e-05	0.000538	CcSEcCtD
Sildenafil—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	9.32e-05	0.000538	CcSEcCtD
Sildenafil—Asthenia—Montelukast—chronic obstructive pulmonary disease	9.27e-05	0.000536	CcSEcCtD
Sildenafil—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	9.19e-05	0.000531	CcSEcCtD
Sildenafil—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	9.18e-05	0.00053	CcSEcCtD
Sildenafil—Pruritus—Montelukast—chronic obstructive pulmonary disease	9.14e-05	0.000528	CcSEcCtD
Sildenafil—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	9.03e-05	0.000522	CcSEcCtD
Sildenafil—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	9.03e-05	0.000522	CcSEcCtD
Sildenafil—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	8.99e-05	0.000519	CcSEcCtD
Sildenafil—Asthenia—Salbutamol—chronic obstructive pulmonary disease	8.94e-05	0.000516	CcSEcCtD
Sildenafil—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	8.84e-05	0.000511	CcSEcCtD
Sildenafil—Pruritus—Salbutamol—chronic obstructive pulmonary disease	8.81e-05	0.000509	CcSEcCtD
Sildenafil—Erythema—Prednisolone—chronic obstructive pulmonary disease	8.76e-05	0.000506	CcSEcCtD
Sildenafil—Dizziness—Formoterol—chronic obstructive pulmonary disease	8.73e-05	0.000504	CcSEcCtD
Sildenafil—Dizziness—Arformoterol—chronic obstructive pulmonary disease	8.73e-05	0.000504	CcSEcCtD
Sildenafil—Dizziness—Montelukast—chronic obstructive pulmonary disease	8.55e-05	0.000494	CcSEcCtD
Sildenafil—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	8.52e-05	0.000492	CcSEcCtD
Sildenafil—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	8.41e-05	0.000486	CcSEcCtD
Sildenafil—Vomiting—Arformoterol—chronic obstructive pulmonary disease	8.39e-05	0.000485	CcSEcCtD
Sildenafil—Vomiting—Formoterol—chronic obstructive pulmonary disease	8.39e-05	0.000485	CcSEcCtD
Sildenafil—Rash—Formoterol—chronic obstructive pulmonary disease	8.32e-05	0.000481	CcSEcCtD
Sildenafil—Rash—Arformoterol—chronic obstructive pulmonary disease	8.32e-05	0.000481	CcSEcCtD
Sildenafil—Dermatitis—Formoterol—chronic obstructive pulmonary disease	8.31e-05	0.00048	CcSEcCtD
Sildenafil—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	8.31e-05	0.00048	CcSEcCtD
Sildenafil—Weight increased—Prednisone—chronic obstructive pulmonary disease	8.31e-05	0.00048	CcSEcCtD
Sildenafil—Headache—Formoterol—chronic obstructive pulmonary disease	8.27e-05	0.000478	CcSEcCtD
Sildenafil—Headache—Arformoterol—chronic obstructive pulmonary disease	8.27e-05	0.000478	CcSEcCtD
Sildenafil—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	8.25e-05	0.000477	CcSEcCtD
Sildenafil—Dizziness—Salbutamol—chronic obstructive pulmonary disease	8.24e-05	0.000476	CcSEcCtD
Sildenafil—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	8.24e-05	0.000476	CcSEcCtD
Sildenafil—Vomiting—Montelukast—chronic obstructive pulmonary disease	8.22e-05	0.000475	CcSEcCtD
Sildenafil—Rash—Montelukast—chronic obstructive pulmonary disease	8.15e-05	0.000471	CcSEcCtD
Sildenafil—Dermatitis—Montelukast—chronic obstructive pulmonary disease	8.14e-05	0.00047	CcSEcCtD
Sildenafil—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	8.12e-05	0.000469	CcSEcCtD
Sildenafil—Depression—Prednisone—chronic obstructive pulmonary disease	8.12e-05	0.000469	CcSEcCtD
Sildenafil—Headache—Montelukast—chronic obstructive pulmonary disease	8.1e-05	0.000468	CcSEcCtD
Sildenafil—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	8.03e-05	0.000464	CcSEcCtD
Sildenafil—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.000461	CcSEcCtD
Sildenafil—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	7.98e-05	0.000461	CcSEcCtD
Sildenafil—Vomiting—Salbutamol—chronic obstructive pulmonary disease	7.92e-05	0.000458	CcSEcCtD
Sildenafil—Malaise—Prednisolone—chronic obstructive pulmonary disease	7.9e-05	0.000456	CcSEcCtD
Sildenafil—Vertigo—Prednisolone—chronic obstructive pulmonary disease	7.87e-05	0.000454	CcSEcCtD
Sildenafil—Rash—Salbutamol—chronic obstructive pulmonary disease	7.86e-05	0.000454	CcSEcCtD
Sildenafil—Syncope—Prednisolone—chronic obstructive pulmonary disease	7.85e-05	0.000454	CcSEcCtD
Sildenafil—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	7.85e-05	0.000453	CcSEcCtD
Sildenafil—Nausea—Formoterol—chronic obstructive pulmonary disease	7.84e-05	0.000453	CcSEcCtD
Sildenafil—Nausea—Arformoterol—chronic obstructive pulmonary disease	7.84e-05	0.000453	CcSEcCtD
Sildenafil—Headache—Salbutamol—chronic obstructive pulmonary disease	7.81e-05	0.000451	CcSEcCtD
Sildenafil—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	7.7e-05	0.000445	CcSEcCtD
Sildenafil—Nausea—Montelukast—chronic obstructive pulmonary disease	7.68e-05	0.000444	CcSEcCtD
Sildenafil—Convulsion—Prednisolone—chronic obstructive pulmonary disease	7.59e-05	0.000438	CcSEcCtD
Sildenafil—Hypertension—Prednisolone—chronic obstructive pulmonary disease	7.56e-05	0.000437	CcSEcCtD
Sildenafil—Nausea—Salbutamol—chronic obstructive pulmonary disease	7.4e-05	0.000428	CcSEcCtD
Sildenafil—Discomfort—Prednisolone—chronic obstructive pulmonary disease	7.37e-05	0.000425	CcSEcCtD
Sildenafil—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	7.35e-05	0.000424	CcSEcCtD
Sildenafil—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	7.31e-05	0.000422	CcSEcCtD
Sildenafil—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	7.18e-05	0.000415	CcSEcCtD
Sildenafil—Oedema—Prednisolone—chronic obstructive pulmonary disease	7.15e-05	0.000413	CcSEcCtD
Sildenafil—Shock—Prednisolone—chronic obstructive pulmonary disease	7.03e-05	0.000406	CcSEcCtD
Sildenafil—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	6.97e-05	0.000403	CcSEcCtD
Sildenafil—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	6.91e-05	0.000399	CcSEcCtD
Sildenafil—Eye disorder—Prednisone—chronic obstructive pulmonary disease	6.83e-05	0.000395	CcSEcCtD
Sildenafil—Flushing—Prednisone—chronic obstructive pulmonary disease	6.78e-05	0.000392	CcSEcCtD
Sildenafil—Angiopathy—Prednisone—chronic obstructive pulmonary disease	6.63e-05	0.000383	CcSEcCtD
Sildenafil—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	6.6e-05	0.000381	CcSEcCtD
Sildenafil—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	6.53e-05	0.000377	CcSEcCtD
Sildenafil—Insomnia—Prednisolone—chronic obstructive pulmonary disease	6.46e-05	0.000373	CcSEcCtD
Sildenafil—Alopecia—Prednisone—chronic obstructive pulmonary disease	6.46e-05	0.000373	CcSEcCtD
Sildenafil—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	6.42e-05	0.000371	CcSEcCtD
Sildenafil—Mental disorder—Prednisone—chronic obstructive pulmonary disease	6.4e-05	0.00037	CcSEcCtD
Sildenafil—Erythema—Prednisone—chronic obstructive pulmonary disease	6.36e-05	0.000368	CcSEcCtD
Sildenafil—Malnutrition—Prednisone—chronic obstructive pulmonary disease	6.36e-05	0.000368	CcSEcCtD
Sildenafil—Pain—Prednisolone—chronic obstructive pulmonary disease	6.11e-05	0.000353	CcSEcCtD
Sildenafil—Vision blurred—Prednisone—chronic obstructive pulmonary disease	6e-05	0.000346	CcSEcCtD
Sildenafil—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	5.9e-05	0.000341	CcSEcCtD
Sildenafil—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	5.89e-05	0.00034	CcSEcCtD
Sildenafil—Anaemia—Prednisone—chronic obstructive pulmonary disease	5.88e-05	0.00034	CcSEcCtD
Sildenafil—Agitation—Prednisone—chronic obstructive pulmonary disease	5.85e-05	0.000338	CcSEcCtD
Sildenafil—Malaise—Prednisone—chronic obstructive pulmonary disease	5.74e-05	0.000331	CcSEcCtD
Sildenafil—Vertigo—Prednisone—chronic obstructive pulmonary disease	5.72e-05	0.00033	CcSEcCtD
Sildenafil—Syncope—Prednisone—chronic obstructive pulmonary disease	5.71e-05	0.00033	CcSEcCtD
Sildenafil—Urticaria—Prednisolone—chronic obstructive pulmonary disease	5.68e-05	0.000328	CcSEcCtD
Sildenafil—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	5.59e-05	0.000323	CcSEcCtD
Sildenafil—Convulsion—Prednisone—chronic obstructive pulmonary disease	5.51e-05	0.000318	CcSEcCtD
Sildenafil—Hypertension—Prednisone—chronic obstructive pulmonary disease	5.49e-05	0.000317	CcSEcCtD
Sildenafil—Myalgia—Prednisone—chronic obstructive pulmonary disease	5.42e-05	0.000313	CcSEcCtD
Sildenafil—Arthralgia—Prednisone—chronic obstructive pulmonary disease	5.42e-05	0.000313	CcSEcCtD
Sildenafil—Anxiety—Prednisone—chronic obstructive pulmonary disease	5.4e-05	0.000312	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	5.38e-05	0.000311	CcSEcCtD
Sildenafil—Discomfort—Prednisone—chronic obstructive pulmonary disease	5.35e-05	0.000309	CcSEcCtD
Sildenafil—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	5.26e-05	0.000304	CcSEcCtD
Sildenafil—Oedema—Prednisone—chronic obstructive pulmonary disease	5.19e-05	0.0003	CcSEcCtD
Sildenafil—Infection—Prednisone—chronic obstructive pulmonary disease	5.16e-05	0.000298	CcSEcCtD
Sildenafil—Shock—Prednisone—chronic obstructive pulmonary disease	5.11e-05	0.000295	CcSEcCtD
Sildenafil—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	5.09e-05	0.000294	CcSEcCtD
Sildenafil—Tachycardia—Prednisone—chronic obstructive pulmonary disease	5.07e-05	0.000293	CcSEcCtD
Sildenafil—Skin disorder—Prednisone—chronic obstructive pulmonary disease	5.04e-05	0.000291	CcSEcCtD
Sildenafil—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	5.02e-05	0.00029	CcSEcCtD
Sildenafil—Anorexia—Prednisone—chronic obstructive pulmonary disease	4.95e-05	0.000286	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	4.73e-05	0.000273	CcSEcCtD
Sildenafil—Dizziness—Prednisolone—chronic obstructive pulmonary disease	4.73e-05	0.000273	CcSEcCtD
Sildenafil—Insomnia—Prednisone—chronic obstructive pulmonary disease	4.7e-05	0.000271	CcSEcCtD
Sildenafil—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	4.66e-05	0.000269	CcSEcCtD
Sildenafil—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	4.57e-05	0.000264	CcSEcCtD
Sildenafil—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	4.51e-05	0.000261	CcSEcCtD
Sildenafil—Rash—Prednisolone—chronic obstructive pulmonary disease	4.51e-05	0.00026	CcSEcCtD
Sildenafil—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	4.5e-05	0.00026	CcSEcCtD
Sildenafil—Fatigue—Prednisone—chronic obstructive pulmonary disease	4.48e-05	0.000259	CcSEcCtD
Sildenafil—Headache—Prednisolone—chronic obstructive pulmonary disease	4.48e-05	0.000259	CcSEcCtD
Sildenafil—Constipation—Prednisone—chronic obstructive pulmonary disease	4.44e-05	0.000257	CcSEcCtD
Sildenafil—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	4.28e-05	0.000247	CcSEcCtD
Sildenafil—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	4.25e-05	0.000245	CcSEcCtD
Sildenafil—Nausea—Prednisolone—chronic obstructive pulmonary disease	4.24e-05	0.000245	CcSEcCtD
Sildenafil—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	4.15e-05	0.000758	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	4.14e-05	0.000756	CbGpPWpGaD
Sildenafil—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.13e-05	0.000754	CbGpPWpGaD
Sildenafil—Urticaria—Prednisone—chronic obstructive pulmonary disease	4.13e-05	0.000238	CcSEcCtD
Sildenafil—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	4.1e-05	0.000237	CcSEcCtD
Sildenafil—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	4.1e-05	0.000237	CcSEcCtD
Sildenafil—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	4.09e-05	0.000748	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	4.09e-05	0.000747	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—KL—chronic obstructive pulmonary disease	4.02e-05	0.000735	CbGpPWpGaD
Sildenafil—ABCC4—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.99e-05	0.000729	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.85e-05	0.000703	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.84e-05	0.000702	CbGpPWpGaD
Sildenafil—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	3.83e-05	0.000221	CcSEcCtD
Sildenafil—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.8e-05	0.000694	CbGpPWpGaD
Sildenafil—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.74e-05	0.000684	CbGpPWpGaD
Sildenafil—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.74e-05	0.000684	CbGpPWpGaD
Sildenafil—Asthenia—Prednisone—chronic obstructive pulmonary disease	3.73e-05	0.000215	CcSEcCtD
Sildenafil—PDE6G—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.71e-05	0.000679	CbGpPWpGaD
Sildenafil—Pruritus—Prednisone—chronic obstructive pulmonary disease	3.67e-05	0.000212	CcSEcCtD
Sildenafil—PDE6G—Disease—NOS2—chronic obstructive pulmonary disease	3.59e-05	0.000656	CbGpPWpGaD
Sildenafil—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	3.55e-05	0.000205	CcSEcCtD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	3.51e-05	0.000641	CbGpPWpGaD
Sildenafil—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.49e-05	0.000638	CbGpPWpGaD
Sildenafil—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.49e-05	0.000637	CbGpPWpGaD
Sildenafil—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	3.46e-05	0.000632	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—APIP—chronic obstructive pulmonary disease	3.45e-05	0.00063	CbGpPWpGaD
Sildenafil—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.44e-05	0.000629	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—APIP—chronic obstructive pulmonary disease	3.44e-05	0.000629	CbGpPWpGaD
Sildenafil—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.44e-05	0.000629	CbGpPWpGaD
Sildenafil—Dizziness—Prednisone—chronic obstructive pulmonary disease	3.43e-05	0.000198	CcSEcCtD
Sildenafil—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	3.41e-05	0.000624	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—chronic obstructive pulmonary disease	3.39e-05	0.000619	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.36e-05	0.000615	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HDAC2—chronic obstructive pulmonary disease	3.34e-05	0.00061	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.33e-05	0.000608	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.32e-05	0.000606	CbGpPWpGaD
Sildenafil—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	3.32e-05	0.000606	CbGpPWpGaD
Sildenafil—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.31e-05	0.000604	CbGpPWpGaD
Sildenafil—Vomiting—Prednisone—chronic obstructive pulmonary disease	3.3e-05	0.000191	CcSEcCtD
Sildenafil—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	3.29e-05	0.000602	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GCLC—chronic obstructive pulmonary disease	3.29e-05	0.000601	CbGpPWpGaD
Sildenafil—Rash—Prednisone—chronic obstructive pulmonary disease	3.27e-05	0.000189	CcSEcCtD
Sildenafil—Dermatitis—Prednisone—chronic obstructive pulmonary disease	3.27e-05	0.000189	CcSEcCtD
Sildenafil—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3.26e-05	0.000596	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	3.26e-05	0.000595	CbGpPWpGaD
Sildenafil—Headache—Prednisone—chronic obstructive pulmonary disease	3.25e-05	0.000188	CcSEcCtD
Sildenafil—CYP1A1—Metabolism—APIP—chronic obstructive pulmonary disease	3.25e-05	0.000594	CbGpPWpGaD
Sildenafil—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.21e-05	0.000586	CbGpPWpGaD
Sildenafil—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	3.18e-05	0.000581	CbGpPWpGaD
Sildenafil—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.16e-05	0.000578	CbGpPWpGaD
Sildenafil—PDE5A—Hemostasis—TP53—chronic obstructive pulmonary disease	3.16e-05	0.000578	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.15e-05	0.000576	CbGpPWpGaD
Sildenafil—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	3.14e-05	0.000573	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	3.14e-05	0.000573	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	3.12e-05	0.00057	CbGpPWpGaD
Sildenafil—ABCC5—Disease—KL—chronic obstructive pulmonary disease	3.1e-05	0.000567	CbGpPWpGaD
Sildenafil—Nausea—Prednisone—chronic obstructive pulmonary disease	3.08e-05	0.000178	CcSEcCtD
Sildenafil—ABCC4—Hemostasis—MMP1—chronic obstructive pulmonary disease	3.08e-05	0.000563	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	3.07e-05	0.00056	CbGpPWpGaD
Sildenafil—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.04e-05	0.000556	CbGpPWpGaD
Sildenafil—PDE6G—Disease—SERPINE1—chronic obstructive pulmonary disease	3.02e-05	0.000553	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—PLAU—chronic obstructive pulmonary disease	3.02e-05	0.000552	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	3.02e-05	0.000551	CbGpPWpGaD
Sildenafil—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	3.02e-05	0.000551	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—CTGF—chronic obstructive pulmonary disease	3e-05	0.000548	CbGpPWpGaD
Sildenafil—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	3e-05	0.000548	CbGpPWpGaD
Sildenafil—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.97e-05	0.000543	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	2.96e-05	0.00054	CbGpPWpGaD
Sildenafil—ABCC5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.91e-05	0.000533	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.9e-05	0.00053	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.9e-05	0.00053	CbGpPWpGaD
Sildenafil—PDE6G—Disease—NOS3—chronic obstructive pulmonary disease	2.89e-05	0.000528	CbGpPWpGaD
Sildenafil—ABCC4—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	2.86e-05	0.000523	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.85e-05	0.000521	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—NOS2—chronic obstructive pulmonary disease	2.78e-05	0.000507	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.76e-05	0.000505	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.74e-05	0.0005	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.7e-05	0.000493	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.7e-05	0.000493	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	2.68e-05	0.00049	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	2.66e-05	0.000486	CbGpPWpGaD
Sildenafil—ADORA2A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2.66e-05	0.000485	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	2.64e-05	0.000483	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	2.61e-05	0.000476	CbGpPWpGaD
Sildenafil—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—chronic obstructive pulmonary disease	2.6e-05	0.000476	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.53e-05	0.000462	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	2.53e-05	0.000461	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	2.45e-05	0.000447	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.43e-05	0.000443	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	2.4e-05	0.000438	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.34e-05	0.000427	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—ALB—chronic obstructive pulmonary disease	2.33e-05	0.000426	CbGpPWpGaD
Sildenafil—ABCC5—Disease—ERBB3—chronic obstructive pulmonary disease	2.33e-05	0.000425	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.32e-05	0.000424	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	2.31e-05	0.000422	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.31e-05	0.000421	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.28e-05	0.000417	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.28e-05	0.000417	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.28e-05	0.000416	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.27e-05	0.000415	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.25e-05	0.000411	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—NOS3—chronic obstructive pulmonary disease	2.23e-05	0.000408	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GC—chronic obstructive pulmonary disease	2.22e-05	0.000406	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	2.22e-05	0.000405	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.15e-05	0.000393	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.14e-05	0.00039	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.12e-05	0.000387	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.12e-05	0.000387	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	2.1e-05	0.000383	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.1e-05	0.000383	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GC—chronic obstructive pulmonary disease	2.09e-05	0.000383	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.07e-05	0.000378	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.07e-05	0.000377	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.06e-05	0.000377	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.02e-05	0.000369	CbGpPWpGaD
Sildenafil—ABCC4—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.02e-05	0.000369	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.01e-05	0.000367	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by NGF—IL6—chronic obstructive pulmonary disease	2e-05	0.000366	CbGpPWpGaD
Sildenafil—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.99e-05	0.000363	CbGpPWpGaD
Sildenafil—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.96e-05	0.000358	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.95e-05	0.000356	CbGpPWpGaD
Sildenafil—ABCC5—Disease—NOS2—chronic obstructive pulmonary disease	1.94e-05	0.000354	CbGpPWpGaD
Sildenafil—PDE6G—Disease—TGFB1—chronic obstructive pulmonary disease	1.91e-05	0.000349	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.9e-05	0.000347	CbGpPWpGaD
Sildenafil—PDE6G—Disease—EGFR—chronic obstructive pulmonary disease	1.87e-05	0.000342	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.85e-05	0.000338	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.79e-05	0.000328	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.76e-05	0.000322	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.75e-05	0.000319	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.73e-05	0.000316	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.72e-05	0.000314	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.71e-05	0.000313	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.68e-05	0.000306	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.66e-05	0.000303	CbGpPWpGaD
Sildenafil—ABCC5—Disease—SERPINE1—chronic obstructive pulmonary disease	1.63e-05	0.000298	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.62e-05	0.000296	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.62e-05	0.000296	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.61e-05	0.000294	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.61e-05	0.000294	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.6e-05	0.000292	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.59e-05	0.000291	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.59e-05	0.000291	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.59e-05	0.00029	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.58e-05	0.000288	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.56e-05	0.000286	CbGpPWpGaD
Sildenafil—ABCC5—Disease—NOS3—chronic obstructive pulmonary disease	1.56e-05	0.000285	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.51e-05	0.000276	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.48e-05	0.00027	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.47e-05	0.000268	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.46e-05	0.000266	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.45e-05	0.000266	CbGpPWpGaD
Sildenafil—PDE6G—Disease—IL6—chronic obstructive pulmonary disease	1.44e-05	0.000263	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	1.43e-05	0.000261	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.42e-05	0.000259	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.39e-05	0.000254	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—ALB—chronic obstructive pulmonary disease	1.37e-05	0.000249	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.34e-05	0.000244	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.31e-05	0.00024	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—NOS3—chronic obstructive pulmonary disease	1.31e-05	0.000239	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.3e-05	0.000237	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.29e-05	0.000235	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.27e-05	0.000232	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.24e-05	0.000226	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—chronic obstructive pulmonary disease	1.22e-05	0.000222	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.21e-05	0.000222	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.21e-05	0.000221	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.2e-05	0.000219	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	1.2e-05	0.000219	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.16e-05	0.000212	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.16e-05	0.000212	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.15e-05	0.000211	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.15e-05	0.000209	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.14e-05	0.000209	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.13e-05	0.000207	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.1e-05	0.000201	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.09e-05	0.0002	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	1.09e-05	0.0002	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.07e-05	0.000195	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.06e-05	0.000194	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.05e-05	0.000193	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.03e-05	0.000189	CbGpPWpGaD
Sildenafil—ABCC5—Disease—TGFB1—chronic obstructive pulmonary disease	1.03e-05	0.000188	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	1.03e-05	0.000188	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.01e-05	0.000185	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EGFR—chronic obstructive pulmonary disease	1.01e-05	0.000185	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.01e-05	0.000184	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.01e-05	0.000184	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.01e-05	0.000184	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.58e-06	0.000175	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.51e-06	0.000174	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	9.47e-06	0.000173	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.37e-06	0.000171	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	9.26e-06	0.000169	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	9.04e-06	0.000165	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	8.63e-06	0.000158	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.63e-06	0.000158	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.61e-06	0.000157	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.54e-06	0.000156	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	8.51e-06	0.000156	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	8.45e-06	0.000154	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	8.44e-06	0.000154	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.41e-06	0.000154	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.4e-06	0.000153	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.3e-06	0.000152	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.28e-06	0.000151	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	7.93e-06	0.000145	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.87e-06	0.000144	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	7.82e-06	0.000143	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.78e-06	0.000142	CbGpPWpGaD
Sildenafil—ABCC5—Disease—IL6—chronic obstructive pulmonary disease	7.77e-06	0.000142	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	7.77e-06	0.000142	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.73e-06	0.000141	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.72e-06	0.000141	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	7.7e-06	0.000141	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	7.66e-06	0.00014	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.33e-06	0.000134	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.31e-06	0.000134	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.29e-06	0.000133	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	7.28e-06	0.000133	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.16e-06	0.000131	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.1e-06	0.00013	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.93e-06	0.000127	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	6.88e-06	0.000126	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	6.58e-06	0.00012	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.49e-06	0.000119	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.4e-06	0.000117	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	6.22e-06	0.000114	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.97e-06	0.000109	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.97e-06	0.000109	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.92e-06	0.000108	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.89e-06	0.000108	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.84e-06	0.000107	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	5.71e-06	0.000104	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.65e-06	0.000103	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.63e-06	0.000103	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	5.6e-06	0.000102	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	5.57e-06	0.000102	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.49e-06	0.0001	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.44e-06	9.94e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.2e-06	9.5e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.16e-06	9.42e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	5.08e-06	9.28e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—ALB—chronic obstructive pulmonary disease	4.98e-06	9.1e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	4.97e-06	9.08e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.77e-06	8.71e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	4.76e-06	8.69e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.7e-06	8.58e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—ALB—chronic obstructive pulmonary disease	4.7e-06	8.58e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.68e-06	8.55e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	4.49e-06	8.21e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.3e-06	7.86e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.9e-06	7.13e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.85e-06	7.03e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	3.84e-06	7.02e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	3.68e-06	6.72e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.59e-06	6.55e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	3.54e-06	6.46e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	3.5e-06	6.4e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.4e-06	6.21e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	3.38e-06	6.18e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	3.35e-06	6.13e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	2.31e-06	4.22e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	2.21e-06	4.04e-05	CbGpPWpGaD
